The Future of Drug Development Reimagined: Agentic AI and the Functionless Pharma Model

About this ebook

What's inside

Pharma R&D is at a crossroads. Traditional models are slow, siloed, and costly—drug development timelines stretch over a decade, and costs have doubled every nine years. This executive guide introduces Agentic AI, a breakthrough approach where autonomous AI agents orchestrate end-to-end workflows, eliminating inefficiencies and enabling functionless organizations. It shows how this paradigm will redefine drug development over the next decade—promising 30–50% cost reduction, 6–12 months faster timelines, and personalized, patient-driven therapies for C-suite executives, R&D leaders, and digital transformation teams.

Key takeaways

What you'll learn

• What Agentic AI is—why it's more than just automation, and how it acts rather than simply informs.
• The 3/5/10-year outlook: from AI-assisted trials to fully autonomous drug development.
• Key enabling technologies: LLMs, RAG, multi-agent orchestration, digital twins, and federated learning.
• Use cases across R&D: protocol design, patient recruitment, trial monitoring, and regulatory submissions.
• A strategic roadmap for how pharma leaders can prepare for this transformation.